Reis, I. M., Ramachandran, K., Speer, C., Gordian, E., & Singal, R. (2015). Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease. Br J Cancer.
Stile di citazione ChicagoReis, I M., K. Ramachandran, C. Speer, E. Gordian, e R. Singal. "Serum GADD45a Methylation Is a Useful Biomarker to Distinguish Benign Vs Malignant Prostate Disease." Br J Cancer 2015.
Citazione MLAReis, I M., et al. "Serum GADD45a Methylation Is a Useful Biomarker to Distinguish Benign Vs Malignant Prostate Disease." Br J Cancer 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.